Featured
Featured
Featured
Featured
Featured
menu
search
You are here
Press Releases
Press Releases
RSS 
CSV
XLSX
NIH scientists try a new twist on using ‘personalized’ stem cells for studying dementia
Wednesday, April 7, 2021
In an article published in the journal Neuron, NIH researchers outlined their plans for the iPSC Neurodegenerative Disease Initiative (iNDI), a project designed to help scientists better understand how genetic mutations lead to the brain cell damage underlying Alzheimer’s disease and other...
DNA damage “hot spots” discovered within neurons
Thursday, March 25, 2021
NIH labs collaborate to develop new methods for studying genome-wide DNA damage and repair
WHAT:
NIMH’s Dr. Andrea Beckel-Mitchener Named Deputy Director of NIH BRAIN Initiative
Friday, March 5, 2021
NIH has announced the selection of Andrea Beckel-Mitchener, Ph.D., of the National Institute of Mental Health (NIMH), as deputy director of the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative.
Leading migraine researcher supported by the NIH wins The Brain Prize 2021
Friday, March 5, 2021
The Brain Prize has been awarded to Michael A. Moskowitz, M.D., a professor of neurology at Harvard Medical School at the Massachusetts General Hospital, Charlestown, who also is supported by an NIH grant.
Genetic study of Lewy body dementia supports ties to Alzheimer’s and Parkinson’s diseases
Tuesday, February 16, 2021
In a study led by NIH researchers, scientists found that five genes may play a critical role in determining whether a person will suffer from Lewy body dementia, a devastating disorder that riddles the brain with clumps of abnormal protein deposits called Lewy bodies
Combination treatment for common glioma type shows promise in mice
Tuesday, February 16, 2021
In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas—a type of slow-growing glioma—and found tumor regression in 60 percent of the mice treated.
NINDS Names Dr. Amy Bany Adams as Deputy Director for Scientific Management and Operations
Wednesday, February 3, 2021
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has named Amy Bany Adams, Ph.D., as Deputy Director for Scientific Management and Operations (DDSMO).
NIH launches database to track neurological symptoms associated with COVID-19
Tuesday, January 26, 2021
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions.
Timing is of the essence when treating brain swelling in mice
Monday, January 18, 2021
Researchers from the National Institutes of Health have discovered Jekyll and Hyde immune cells in the brain that ultimately help with brain repair but early after injury can lead to fatal swelling, suggesting that timing may be critical when administering treatment.
